Novartis Institutes For Bio Medical Research, Inc. Surface Oncology, Inc. (SURF) insider trading activity

Novartis Institutes For Bio Medical Research, Inc. is > 10% Shareholder of Surface Oncology, Inc.. Currently has a direct ownership of 3.95 Million shares of SURF, which is worth approximately $0. The most recent transaction as insider was on Apr 23, 2018, when has been sold 766,666 shares (Common Stock) at a price of $15.0 per share, resulting in proceeds of $11,499,990. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 3.95M

0% 3M change

0% 12M change

Total Value Held $0

Novartis Institutes for BioMedical Research, Inc. Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Apr 23 2018	BUY Open market or private purchase	$11,499,990 $15.0 p/Share	766,666 Added 16.26%	3,948,482 Common Stock
Apr 23 2018	BUY Conversion of derivative security	-	3,181,816 Added 50.0%	3,181,816 Common Stock

Also insider at

NTLA

Intellia Therapeutics, Inc. Healthcare

> 10% Shareholder

FIXX

Homology Medicines, Inc. Healthcare

> 10% Shareholder

NIf